By Nigam Arora The Arora Report released new buy zones for 39 widely followed stocks. These powerful zones identify optimal entry points based on deep technical, fundamental, and macroeconomic analysis. Market pullbacks create opportunities. Investors who are prepared and who use buy zones maximize risk adjusted returns. Opportunities For Tactical Positions
By Nigam Arora To gain an edge, this is what you need to know today. Key Earnings Data Please click here for a chart of Nvidia stock (NVDA). Note the following: The Morning Capsule is about the big picture, not an individual stock. The chart of NVDA stock is being used
By Nigam Arora To gain an edge, this is what you need to know today. Dip Buyers Save The Market Please click here for a chart of Nasdaq 100 ETF (QQQ). Note the following: The chart shows QQQ was weakening going into Friday morning. The chart shows mindless dip buying saved
By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules
By Nigam Arora To gain an edge, this is what you need to know today. Fed Fears Please click here for a chart of Nasdaq 100 ETF (QQQ). Note the following: The chart shows QQQ has dipped into zone 1 (support). The chart shows QQQ is making a lower low than
By Nigam Arora On October 17th, our paid members were alerted that a major development on weight loss drug pricing was likely coming and that it could significantly impact Eli Lilly (LLY) stock. Yesterday, there was a signal in ZYX Buy on a key development that could materially impact LLY stock.
By Nigam Arora To gain an edge, this is what you need to know today. AI Share Please click here for a chart of Advanced Micro Devices stock (AMD). Note the following: The Morning Capsule is about the big picture, not an individual stock. The chart of AMD stock is being
By Nigam Arora Editor’s note: This post was published yesterday in The Arora Report paid feeds. 217th Buyout Novo Nordisk (NVO) and Pfizer (PFE) have been in a bidding war over biotech Metsera (MTSR). Pfizer prevailed, making Metsera the 217th Arora portfolio company to be bought out. Late Friday evening, MTSR stock
By Nigam Arora To gain an edge, this is what you need to know today. Aggressive Stock Buying Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The chart shows the stock market was falling rapidly
By Nigam Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning